[PDF][PDF] MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer

JC Dudda, B Salaun, Y Ji, DC Palmer, GC Monnot… - Immunity, 2013 - cell.com
JC Dudda, B Salaun, Y Ji, DC Palmer, GC Monnot, E Merck, C Boudousquie…
Immunity, 2013cell.com
MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in
promoting CD8+ T cell immunity remains unknown. Here we report that miRNA-155 is
required for CD8+ T cell responses to both virus and cancer. In the absence of miRNA-155,
accumulation of effector CD8+ T cells was severely reduced during acute and chronic viral
infections and control of virus replication was impaired. Similarly, Mir155−/− CD8+ T cells
were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced …
Summary
MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8+ T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8+ T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8+ T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155−/− CD8+ T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8+ T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8+ T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.
cell.com